Icon plc ICLR.US 總覽分析
)ICLR 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分優異，但股利評分未超過2分，若公司開始配息，可能會有更優異的投資結果
ICLR 近期報酬表現
0.29%
Icon plc
0.60%
同產業平均
-0.04%
S&P500
與 ICLR 同產業的標的表現
- TMO Thermo fisher scientific inc.價值 4 分趨勢 1 分波段 4 分籌碼 4 分股利 3 分查看更多
ICLR 公司資訊
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.